Shilpa Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
850.50
-50.4 (-5.59%)
BSENSE

Nov 20

BSE+NSE Vol: 16.58 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Alembic Pharma
Rubicon Research
Alivus Life
Granules India
Caplin Point Lab
Shilpa Medicare
OneSource Speci.
ERIS Lifescience
Cohance Life
Pfizer
Natco Pharma
Why is Shilpa Medicare Ltd ?
1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.53 times
  • Poor long term growth as Net Sales has grown by an annual rate of 14.60% and Operating profit at 41.93% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.53 times
  • The company has been able to generate a Return on Equity (avg) of 3.58% signifying low profitability per unit of shareholders funds
2
Low Debt Company with Strong Long Term Fundamental Strength
3
With a growth in Net Sales of 13.6%, the company declared Very Positive results in Sep 26
  • The company has declared positive results for the last 13 consecutive quarters
  • PAT(Latest six months) At Rs 180.39 cr has Grown at 98.32%
  • NET SALES(Q) Highest at Rs 529.12 cr
  • PBDIT(Q) Highest at Rs 142.40 cr.
4
Stock is technically in a Mildly Bullish range
  • The stocks MACD and KST technical factors are also Bullish
5
With ROCE of 9.8, it has a Very Expensive valuation with a 5.4 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 138.60%, its profits have risen by 92.3% ; the PEG ratio of the company is 0.6
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Shilpa Medicare should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shilpa Medicare for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shilpa Medicare
138.6%
2.98
46.52%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
14.60%
EBIT Growth (5y)
41.93%
EBIT to Interest (avg)
3.22
Debt to EBITDA (avg)
3.81
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.43
Tax Ratio
13.18%
Dividend Payout Ratio
12.49%
Pledged Shares
4.90%
Institutional Holding
20.37%
ROCE (avg)
5.01%
ROE (avg)
3.58%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
52
Industry P/E
40
Price to Book Value
6.42
EV to EBIT
45.06
EV to EBITDA
33.61
EV to Capital Employed
5.38
EV to Sales
9.36
PEG Ratio
0.56
Dividend Yield
0.07%
ROCE (Latest)
9.82%
ROE (Latest)
8.89%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
PAT(Latest six months)

At Rs 180.39 cr has Grown at 98.32%

NET SALES(Q)

Highest at Rs 529.12 cr

PBDIT(Q)

Highest at Rs 142.40 cr.

PBT LESS OI(Q)

Highest at Rs 95.32 cr.

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Shilpa Medicare
Profit After Tax (PAT) - Latest six months
At Rs 180.39 cr has Grown at 98.32%
Year on Year (YoY)
MOJO Watch
PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 529.12 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 142.40 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 95.32 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
At Rs 529.12 cr has Grown at 25.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 420.76 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Shilpa Medicare
Non Operating Income - Quarterly
Highest at Rs 8.64 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income